Market Cap 24.46B
Revenue (ttm) 3.25B
Net Income (ttm) -1.29B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39.59%
Debt to Equity Ratio 0.02
Volume 1,222,100
Avg Vol 1,239,776
Day's Range N/A - N/A
Shares Out 252.88M
Stochastic %K 31%
Beta 1.29
Analysts Strong Sell
Price Target $122.00

Company Profile

BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin a...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
htw7448
htw7448 Sep. 15 at 1:37 PM
$BNTX of course the dhitshiw continues. I ll add more till the crookheads are surrounded by positive facts.
0 · Reply
Sergey_stockdoc
Sergey_stockdoc Sep. 15 at 11:45 AM
$BNTX Investors on here are so ridiculous. They are upset that Moderna moved but this didn’t. What does this tell us? It tells us that it’s not the science that moved Moderna, because if it was it should have never hit the $20’s. It was a short squeeze possibly caused by retailers accumulating on news and some short covering. So in time that will come down from the sky and meet this company in valuation. Based off the price action of BioNtech it is appropriately priced because its sales are years away from producing fruit, and even then its execution risk. So with that all being said, expect a gradual grinding of BNTX at current levels for the foreseeable future and Moderna to come back below $100 again because science alone isn’t enough, it’s cash flows that matter more and both are in negative territory.
0 · Reply
htw7448
htw7448 Sep. 15 at 8:44 AM
$BNTX also the title of the oral presentation today was: “The breaktrough immunotherapy for patients with nscls/sclc”. And medical scientists do not tend to overrate things. But first investors should get their 3 brain cells together!
0 · Reply
htw7448
htw7448 Sep. 15 at 8:27 AM
$BNTX is not Moderna, Moderna is great because its US. They can flip a penny and the investors give it 50% plus. Meanwhile BNTX is very close to deliver a keytruda sucessor with 30 billion annual rev, but hey who cares! Fucking US fanboys should wake up!
0 · Reply
Eurofighter
Eurofighter Sep. 15 at 5:48 AM
$BNTX if Moderna had the same news it would have popped 30% at least
0 · Reply
Crider
Crider Sep. 15 at 2:22 AM
$BNTX any news?
0 · Reply
DrDickTracy
DrDickTracy Sep. 14 at 8:17 PM
$BNTX Still have their last presentation coming in in about 6-7 hours Phase 3 trial results Pop pop pop
1 · Reply
wintogether
wintogether Sep. 14 at 8:07 PM
$BNTX disappointing price action today, but happy for the patients. Hope the company helps improve the standard of care and realizes a good value in the long run.
0 · Reply
Pope_of_Profit
Pope_of_Profit Sep. 14 at 6:52 PM
$BNTX hm might actually be an entry
0 · Reply
taxplanr
taxplanr Sep. 14 at 5:35 PM
The zionist's were covering up COVID vaccines deaths also $MRNA $PFE $BNTX https://www.instagram.com/reel/DdReFG2xP_B/?stkn=ZmRlMnU4bGRwb2gz
4 · Reply
Latest News on BNTX
BioNTech to terminate mid-stage trial of mRNA cancer vaccine

Aug 28, 2026, 9:41 AM EDT - 18 days ago

BioNTech to terminate mid-stage trial of mRNA cancer vaccine

BNTX


BioNTech SE Earnings Call Transcript: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 6 weeks ago

BioNTech SE Earnings Call Transcript: Q2 2026


BioNTech SE Earnings release: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 6 weeks ago

BioNTech SE Earnings release: Q2 2026


BioNTech SE Slides: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 6 weeks ago

BioNTech SE Slides: Q2 2026


BioNTech says Sobi's Oelkers will replace Sahin as CEO

Aug 3, 2026, 5:29 AM EDT - 6 weeks ago

BioNTech says Sobi's Oelkers will replace Sahin as CEO

BNTX


This Biotech's Cancer Portfolio Could End Its Rough Patch

May 27, 2026, 11:07 AM EDT - 3 months ago

This Biotech's Cancer Portfolio Could End Its Rough Patch

BNTX


BioNTech SE Transcript: AGM 2026

May 15, 2026, 8:00 AM EDT - 4 months ago

BioNTech SE Transcript: AGM 2026


BioNTech Announces New ADS Repurchase Program

May 7, 2026, 6:45 AM EDT - 4 months ago

BioNTech Announces New ADS Repurchase Program

BNTX


BioNTech SE Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 4 months ago

BioNTech SE Earnings Call Transcript: Q1 2026


BioNTech SE Earnings release: Q1 2026

May 5, 2026, 8:00 AM EDT - 4 months ago

BioNTech SE Earnings release: Q1 2026


BioNTech SE Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 4 months ago

BioNTech SE Slides: Q1 2026


BioNTech SE Earnings Call Transcript: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

BioNTech SE Earnings Call Transcript: Q4 2025


BioNTech SE Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

BioNTech SE Annual report: Q4 2025


BioNTech SE Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

BioNTech SE Earnings release: Q4 2025


BioNTech SE Slides: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 6 months ago

BioNTech SE Slides: Q4 2025


Scientists behind COVID-19 vaccine will depart BioNTech

Mar 10, 2026, 7:40 AM EDT - 6 months ago

Scientists behind COVID-19 vaccine will depart BioNTech

BNTX


BioNTech Cofounders to Leave to Form New Company

Mar 10, 2026, 6:50 AM EDT - 6 months ago

BioNTech Cofounders to Leave to Form New Company

BNTX


htw7448
htw7448 Sep. 15 at 1:37 PM
$BNTX of course the dhitshiw continues. I ll add more till the crookheads are surrounded by positive facts.
0 · Reply
Sergey_stockdoc
Sergey_stockdoc Sep. 15 at 11:45 AM
$BNTX Investors on here are so ridiculous. They are upset that Moderna moved but this didn’t. What does this tell us? It tells us that it’s not the science that moved Moderna, because if it was it should have never hit the $20’s. It was a short squeeze possibly caused by retailers accumulating on news and some short covering. So in time that will come down from the sky and meet this company in valuation. Based off the price action of BioNtech it is appropriately priced because its sales are years away from producing fruit, and even then its execution risk. So with that all being said, expect a gradual grinding of BNTX at current levels for the foreseeable future and Moderna to come back below $100 again because science alone isn’t enough, it’s cash flows that matter more and both are in negative territory.
0 · Reply
htw7448
htw7448 Sep. 15 at 8:44 AM
$BNTX also the title of the oral presentation today was: “The breaktrough immunotherapy for patients with nscls/sclc”. And medical scientists do not tend to overrate things. But first investors should get their 3 brain cells together!
0 · Reply
htw7448
htw7448 Sep. 15 at 8:27 AM
$BNTX is not Moderna, Moderna is great because its US. They can flip a penny and the investors give it 50% plus. Meanwhile BNTX is very close to deliver a keytruda sucessor with 30 billion annual rev, but hey who cares! Fucking US fanboys should wake up!
0 · Reply
Eurofighter
Eurofighter Sep. 15 at 5:48 AM
$BNTX if Moderna had the same news it would have popped 30% at least
0 · Reply
Crider
Crider Sep. 15 at 2:22 AM
$BNTX any news?
0 · Reply
DrDickTracy
DrDickTracy Sep. 14 at 8:17 PM
$BNTX Still have their last presentation coming in in about 6-7 hours Phase 3 trial results Pop pop pop
1 · Reply
wintogether
wintogether Sep. 14 at 8:07 PM
$BNTX disappointing price action today, but happy for the patients. Hope the company helps improve the standard of care and realizes a good value in the long run.
0 · Reply
Pope_of_Profit
Pope_of_Profit Sep. 14 at 6:52 PM
$BNTX hm might actually be an entry
0 · Reply
taxplanr
taxplanr Sep. 14 at 5:35 PM
The zionist's were covering up COVID vaccines deaths also $MRNA $PFE $BNTX https://www.instagram.com/reel/DdReFG2xP_B/?stkn=ZmRlMnU4bGRwb2gz
4 · Reply
Moin77
Moin77 Sep. 14 at 4:09 PM
$BNTX See you again at $120 🤑
1 · Reply
Samishere
Samishere Sep. 14 at 2:38 PM
0 · Reply
ToRni27
ToRni27 Sep. 14 at 2:14 PM
$BNTX normally 5M shares should have been traded by now. News are not great enough.
2 · Reply
ToRni27
ToRni27 Sep. 14 at 2:11 PM
$BNTX very weak. I am out. Data seems not to be good enough.
0 · Reply
1dayatadime
1dayatadime Sep. 14 at 1:56 PM
$BNTX algos will pick it up and double/triple it
0 · Reply
healthmaster
healthmaster Sep. 14 at 1:49 PM
$BNTX i got a feeling that this will goes to 92$+ before it'll want to go parabolic, to accumulate and generate shorts, short is literally 1% float at the moments.
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Sep. 14 at 1:42 PM
$BNTX LOL Just hold and add if possible. WS crooks at their best. JMO
0 · Reply
wintogether
wintogether Sep. 14 at 1:12 PM
$BNTX for this stock the pre-market volume is quite high given its usual history. Expect this to run to 120 today. Might dip in the morning for a buyable dip.
2 · Reply
OpenOutcrier
OpenOutcrier Sep. 14 at 12:29 PM
$BNTX (+6.2% pre) BioNTech drug shows doubled survival in lung cancer trial https://ooc.bz/l/114051
0 · Reply
Hunchinvestor
Hunchinvestor Sep. 14 at 12:24 PM
$BNTX why not trending
1 · Reply
1dayatadime
1dayatadime Sep. 14 at 12:08 PM
$BNTX almost 100% improvement
0 · Reply
Moin77
Moin77 Sep. 14 at 12:02 PM
$BNTX next Stop 115$
0 · Reply